Phase II Study of Immunotherapy With Tecemotide and Bevacizumab After Chemoradiation in Patients With Unresectable Stage III Non-Squamous Non–Small-Cell Lung Cancer (NS-NSCLC): A Trial of the ECOG-ACRIN Cancer Research Group (E6508)
Titel:
Phase II Study of Immunotherapy With Tecemotide and Bevacizumab After Chemoradiation in Patients With Unresectable Stage III Non-Squamous Non–Small-Cell Lung Cancer (NS-NSCLC): A Trial of the ECOG-ACRIN Cancer Research Group (E6508)
Auteur:
Patel, Jyoti D. Lee, Ju-Whei Carbone, David P. Wagner, Henry Shanker, Anil de Aquino, Maria Teresa P. Horn, Leora Johnson, Melissa L. Gerber, David E. Liu, Jane Jijun Das, Millie S. Al-Nsour, Mohammed Ali Dakhil, Christopher S.R. Ramalingam, Suresh Schiller, Joan H.